31st Annual Congress on Vaccines, Clinical Trials & B2B is scheduled to be held during July 27-28, 2018 Vancouver, Canada. This Vaccines & Clinical Trials 2018 includes a wide range of Keynote presentations, Oral talks, Poster presentations, Symposia, Workshops, Exhibitions and Career development programs.
Conference series LLC Ltd Organizes 3000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference website will provide you list and details about the conferences organize worldwide.
Why to Attend???
Vaccines & Clinical Trials 2018 Conference is a multidisciplinary program with broad participation with members from around the globe focused on learning about Vaccines and its advances. This is your best opportunity to reach the largest assemblage of participants from Vaccines community, Immunology, Clinical research that is from academia, medical groups, related associations, societies and also from government agencies, biomedical and medical device industries.
Vaccines & Clinical Trials 2018 will discuss various disciplines involved in the vaccines research; it will educate health care researchers about design, operation, organizing, and research computing, regulatory aspects. It promotes better understanding by the general public about the importance of vaccines in prevention, diagnosis and treatment of disease. This conference conduct presentations, distribute information, meet with current and potential scientists, make a splash with new research developments, and receive name recognition at this 2-days event. World renowned speakers and the most recent techniques, developments, the newest updates in Vaccines Research are hallmarks of this conference.
Who Should Attend?
-
Principal Investigators
-
Medical Directors
-
Methodologists
-
Directors/Executive Directors
-
Vice Presidents/Senior Vice Presidents/Executive Vice Presidents
-
Heads/Leaders
-
Deans/Senior Professors/Associate Professor/Assistant Professors
-
Research Scholars
-
Scientists
-
Vaccinologists
-
Business Entrepreneurs
-
Students
-
Medical Devices Manufacturing Companies
-
Vaccine Manufacturing Companies
-
Vaccine Developers and Investigators
The vaccine market has very distinct features, which increase the complexity of assessing and understanding pricing and procurement. It is made up of individual markets for individual vaccines or vaccine types, each with their own specificities, particularly on the supply side. Market research analyst predicts the global human vaccine market to grow rapidly at a CAGR of more than 11% by 2020. This market’s steady growth rate is heavily influenced by the inclusion of several pediatric vaccines in the national immunization schedule of various countries. This helps in increasing the consumption of vaccines, which in turn fosters market growth during the predicted period.
Pharmaceutical vaccines industry covers the global market opportunity in full, with data on major competitors, market direction, and the pediatric and adult segments. Reports examine the global vaccines market by region, including the US, South America, EU, Japan, India, and China, as well as by type, including hepatitis, pneumococcal, cervical cancer, and influenza, among others. Market share of major vaccine companies is reported as well. Because of the large number of deadly diseases that have been eliminated through the proliferation of effective vaccines, vaccination is generally viewed as one of the greatest public health achievements during the 20th century. However, risks are associated with using all immunobiologics, and no vaccine is 100% safe or effective.
In 2017, North America is expected to dominate the market. The large share of this geographical segment is attributed to factors such as increasing investments by government organizations and companies to promote immunization as well as develop new vaccines. In 2017, Europe is expected to hold the second largest share of this market. Factors such as availability of funding and venture capital investments for the development of new vaccines and increasing government initiatives are expected to drive market growth in this region.
The vaccines market is highly competitive with the presence of several small and big players. Some of the players in the vaccines market are GlaxoSmithKline plc (U.K.), Pfizer, Inc. (U.S.), Merck & Co., Inc. (U.S.), Sanofi Pasteur SA (France), CSL Limited (Australia), Emergent BioSolutions, Inc. (U.S.), Johnson & Johnson (U.S.), MedImmune, (U.S.), Astellas Pharma Inc. (Japan), Serum Institute of India (India), Bavarian Nordic (Denmark), Mitsubishi Tanabe Pharma Corporation (Japan), and Daiichi Sankyo Company, Limited (Japan).
